Tarun Singhal, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 22 | 2023 | 6259 | 2.590 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 3 | 2021 | 236 | 1.360 |
Why?
|
| Putamen | 2 | 2022 | 291 | 1.310 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 3076 | 1.070 |
Why?
|
| Acetanilides | 3 | 2021 | 168 | 1.020 |
Why?
|
| Microglia | 3 | 2023 | 1261 | 0.880 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2019 | 520 | 0.860 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 32 | 0.830 |
Why?
|
| Meningitis, Aseptic | 1 | 2021 | 59 | 0.780 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2020 | 2013 | 0.750 |
Why?
|
| Radiopharmaceuticals | 8 | 2019 | 2658 | 0.730 |
Why?
|
| Mesencephalon | 1 | 2022 | 327 | 0.710 |
Why?
|
| Septum of Brain | 1 | 2019 | 18 | 0.710 |
Why?
|
| Meningitis, Bacterial | 3 | 2013 | 218 | 0.700 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2019 | 60 | 0.670 |
Why?
|
| Substantia Nigra | 1 | 2020 | 353 | 0.650 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 448 | 0.650 |
Why?
|
| Encephalitis | 1 | 2022 | 423 | 0.630 |
Why?
|
| Methionine | 2 | 2012 | 590 | 0.620 |
Why?
|
| Receptors, GABA | 2 | 2022 | 288 | 0.590 |
Why?
|
| Neuroglia | 1 | 2021 | 925 | 0.520 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 7988 | 0.500 |
Why?
|
| Nervous System Diseases | 2 | 2016 | 1617 | 0.480 |
Why?
|
| Movement Disorders | 2 | 2014 | 444 | 0.460 |
Why?
|
| Nuclear Medicine | 1 | 2016 | 233 | 0.450 |
Why?
|
| Meningocele | 1 | 2013 | 45 | 0.450 |
Why?
|
| Fatigue | 1 | 2020 | 1526 | 0.440 |
Why?
|
| Encephalocele | 1 | 2013 | 135 | 0.420 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2906 | 0.400 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1107 | 0.390 |
Why?
|
| Spinal Cord | 2 | 2016 | 1807 | 0.380 |
Why?
|
| Huntington Disease | 1 | 2017 | 1111 | 0.370 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 941 | 0.350 |
Why?
|
| Bacteremia | 1 | 2016 | 962 | 0.340 |
Why?
|
| Cephalosporins | 2 | 2007 | 203 | 0.340 |
Why?
|
| Brain | 11 | 2023 | 26343 | 0.320 |
Why?
|
| Epilepsy | 3 | 2023 | 3301 | 0.270 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 5705 | 0.260 |
Why?
|
| Glioma | 2 | 2012 | 3388 | 0.260 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 202 | 0.250 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2010 | 1121 | 0.240 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1351 | 0.240 |
Why?
|
| Dementia | 2 | 2014 | 2501 | 0.220 |
Why?
|
| Insecticides | 1 | 2024 | 195 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 35342 | 0.210 |
Why?
|
| Brain Neoplasms | 3 | 2014 | 8829 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 9941 | 0.200 |
Why?
|
| Acanthamoeba | 1 | 2001 | 13 | 0.200 |
Why?
|
| Carbon Radioisotopes | 3 | 2014 | 592 | 0.200 |
Why?
|
| Amebiasis | 1 | 2001 | 34 | 0.200 |
Why?
|
| Anti-Infective Agents | 2 | 2016 | 971 | 0.200 |
Why?
|
| Ketoconazole | 1 | 2001 | 95 | 0.200 |
Why?
|
| Multiple System Atrophy | 1 | 2022 | 122 | 0.190 |
Why?
|
| Diphtheria | 1 | 2000 | 35 | 0.180 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2004 | 427 | 0.180 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2001 | 139 | 0.180 |
Why?
|
| Humans | 49 | 2024 | 742088 | 0.180 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2001 | 316 | 0.180 |
Why?
|
| Albuterol | 1 | 2001 | 208 | 0.180 |
Why?
|
| Meningitis | 1 | 2001 | 216 | 0.170 |
Why?
|
| Rifampin | 1 | 2001 | 315 | 0.170 |
Why?
|
| Contrast Media | 1 | 2012 | 5295 | 0.170 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 3507 | 0.170 |
Why?
|
| Acyclovir | 1 | 2019 | 272 | 0.160 |
Why?
|
| Bronchodilator Agents | 1 | 2001 | 502 | 0.150 |
Why?
|
| Female | 26 | 2023 | 379592 | 0.150 |
Why?
|
| Middle Aged | 15 | 2022 | 213127 | 0.140 |
Why?
|
| Klebsiella | 1 | 2016 | 48 | 0.140 |
Why?
|
| Immunization | 2 | 2001 | 1255 | 0.140 |
Why?
|
| Acinetobacter | 1 | 2016 | 39 | 0.140 |
Why?
|
| Fatal Outcome | 2 | 2019 | 1849 | 0.140 |
Why?
|
| Antifungal Agents | 1 | 2001 | 729 | 0.140 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 2271 | 0.140 |
Why?
|
| Pseudomonas | 1 | 2016 | 117 | 0.140 |
Why?
|
| India | 4 | 2016 | 2187 | 0.130 |
Why?
|
| Status Epilepticus | 1 | 2020 | 444 | 0.130 |
Why?
|
| Male | 22 | 2022 | 349538 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2007 | 2121 | 0.130 |
Why?
|
| Adult | 14 | 2022 | 213712 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2019 | 8297 | 0.120 |
Why?
|
| Malaria | 1 | 2024 | 1232 | 0.120 |
Why?
|
| Disease Outbreaks | 2 | 2000 | 1768 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 2414 | 0.120 |
Why?
|
| Vaccines | 1 | 2022 | 817 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2022 | 2036 | 0.110 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 860 | 0.110 |
Why?
|
| Ethylenediamines | 1 | 2003 | 48 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1060 | 0.110 |
Why?
|
| Technetium | 1 | 2003 | 334 | 0.110 |
Why?
|
| Limbic Encephalitis | 1 | 2012 | 34 | 0.110 |
Why?
|
| Naphthols | 1 | 2012 | 45 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2007 | 7153 | 0.110 |
Why?
|
| Adenovirus Infections, Human | 1 | 2012 | 71 | 0.100 |
Why?
|
| Atrophy | 1 | 2016 | 1576 | 0.100 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2012 | 110 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 1204 | 0.100 |
Why?
|
| Organ Size | 1 | 2016 | 2253 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1728 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5062 | 0.100 |
Why?
|
| Rats, Zucker | 1 | 2010 | 128 | 0.090 |
Why?
|
| Chloramphenicol | 2 | 2007 | 75 | 0.090 |
Why?
|
| Streptozocin | 1 | 2010 | 193 | 0.090 |
Why?
|
| Benzoxazines | 1 | 2012 | 301 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 1871 | 0.090 |
Why?
|
| Oxazines | 1 | 2012 | 298 | 0.090 |
Why?
|
| Ampicillin | 2 | 2007 | 138 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3800 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 518 | 0.090 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2010 | 66 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2009 | 38 | 0.090 |
Why?
|
| Catatonia | 1 | 2012 | 157 | 0.090 |
Why?
|
| Electroencephalography | 2 | 2022 | 6142 | 0.090 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2012 | 475 | 0.090 |
Why?
|
| Dopamine Agonists | 1 | 2012 | 355 | 0.090 |
Why?
|
| Pyrrolidinones | 1 | 2009 | 117 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2014 | 503 | 0.080 |
Why?
|
| Aged | 8 | 2023 | 162944 | 0.080 |
Why?
|
| Appendix | 1 | 2009 | 110 | 0.080 |
Why?
|
| Recurrence | 2 | 2013 | 8333 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2774 | 0.080 |
Why?
|
| Community-Acquired Infections | 3 | 2007 | 463 | 0.080 |
Why?
|
| Neoplasms | 2 | 2016 | 21596 | 0.080 |
Why?
|
| Penicillins | 2 | 2007 | 378 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2019 | 2978 | 0.070 |
Why?
|
| Morpholines | 1 | 2010 | 561 | 0.070 |
Why?
|
| Appendectomy | 1 | 2009 | 400 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2018 | 2933 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2010 | 460 | 0.070 |
Why?
|
| Propofol | 1 | 2012 | 628 | 0.070 |
Why?
|
| Radionuclide Imaging | 2 | 2004 | 2027 | 0.070 |
Why?
|
| Asthma | 2 | 2001 | 5955 | 0.060 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 215 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77098 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 39004 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 1158 | 0.060 |
Why?
|
| Child | 11 | 2024 | 77478 | 0.060 |
Why?
|
| Hypertension | 1 | 2004 | 8455 | 0.060 |
Why?
|
| Burkina Faso | 1 | 2024 | 88 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2016 | 4214 | 0.060 |
Why?
|
| Adolescent | 7 | 2022 | 85649 | 0.060 |
Why?
|
| Disease Progression | 1 | 2020 | 13256 | 0.060 |
Why?
|
| Parasitemia | 1 | 2024 | 174 | 0.060 |
Why?
|
| Animals | 7 | 2022 | 168561 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2016 | 8925 | 0.060 |
Why?
|
| Climate | 1 | 2024 | 147 | 0.060 |
Why?
|
| Appendicitis | 1 | 2009 | 644 | 0.060 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 365 | 0.050 |
Why?
|
| Child, Preschool | 9 | 2024 | 40955 | 0.050 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2007 | 454 | 0.050 |
Why?
|
| Organometallic Compounds | 1 | 2006 | 665 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2007 | 688 | 0.050 |
Why?
|
| Immunocompromised Host | 2 | 2012 | 847 | 0.050 |
Why?
|
| Intermediate Filaments | 1 | 2022 | 175 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2022 | 198 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2022 | 524 | 0.050 |
Why?
|
| Bronchitis | 1 | 2001 | 201 | 0.050 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2000 | 56 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2022 | 318 | 0.050 |
Why?
|
| Acute Disease | 2 | 2007 | 7141 | 0.040 |
Why?
|
| Autopsy | 1 | 2022 | 1006 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2488 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2016 | 53187 | 0.040 |
Why?
|
| Cost Control | 1 | 2001 | 624 | 0.040 |
Why?
|
| Amyloid | 1 | 2023 | 795 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 4246 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 1589 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 56350 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2001 | 693 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2001 | 681 | 0.040 |
Why?
|
| Infant | 7 | 2024 | 35070 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 724 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2024 | 2303 | 0.030 |
Why?
|
| Insulin | 1 | 2010 | 6575 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2016 | 40450 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 1998 | 314 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3391 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2001 | 959 | 0.030 |
Why?
|
| Rats | 1 | 2010 | 24265 | 0.030 |
Why?
|
| Length of Stay | 1 | 2007 | 6294 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3164 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 2522 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 3913 | 0.030 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2003 | 66 | 0.030 |
Why?
|
| Inflammation | 1 | 2013 | 10578 | 0.030 |
Why?
|
| Leukemia, Prolymphocytic, T-Cell | 1 | 2012 | 21 | 0.030 |
Why?
|
| Kidney | 2 | 2022 | 7167 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 1178 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12958 | 0.030 |
Why?
|
| Prognosis | 1 | 2012 | 29010 | 0.030 |
Why?
|
| Herpesvirus 6, Human | 1 | 2012 | 95 | 0.030 |
Why?
|
| Logistic Models | 2 | 2024 | 13403 | 0.030 |
Why?
|
| Palliative Care | 1 | 2006 | 3478 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6483 | 0.020 |
Why?
|
| Pain | 1 | 2006 | 4961 | 0.020 |
Why?
|
| Weight Loss | 1 | 2022 | 2604 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2012 | 1159 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3256 | 0.020 |
Why?
|
| Psychomotor Agitation | 1 | 2012 | 288 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3574 | 0.020 |
Why?
|
| Comorbidity | 1 | 2004 | 10372 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 165 | 0.020 |
Why?
|
| Pneumonia | 1 | 2001 | 2117 | 0.020 |
Why?
|
| Aging | 2 | 2022 | 8626 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2009 | 587 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2012 | 741 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 57683 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2851 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2010 | 312 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2009 | 414 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1802 | 0.020 |
Why?
|
| Prevalence | 1 | 2004 | 15194 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 981 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2012 | 1101 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9144 | 0.020 |
Why?
|
| Platelet Count | 2 | 1999 | 780 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 1574 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 1847 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 2378 | 0.020 |
Why?
|
| Incidence | 2 | 2000 | 20928 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15244 | 0.020 |
Why?
|
| Heart Diseases | 1 | 1998 | 2789 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2000 | 4250 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 4771 | 0.020 |
Why?
|
| Cocaine | 1 | 2010 | 1008 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 24913 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2009 | 1059 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 62966 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 2001 | 211 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 2684 | 0.010 |
Why?
|
| China | 1 | 2006 | 2246 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2003 | 4393 | 0.010 |
Why?
|
| Linear Models | 1 | 2009 | 5948 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 2000 | 499 | 0.010 |
Why?
|
| Pneumonia, Bacterial | 1 | 2001 | 316 | 0.010 |
Why?
|
| Immunologic Tests | 1 | 1999 | 103 | 0.010 |
Why?
|
| Hematocrit | 1 | 1999 | 636 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2001 | 850 | 0.010 |
Why?
|
| Dengue Virus | 1 | 1999 | 204 | 0.010 |
Why?
|
| Family Characteristics | 1 | 2001 | 999 | 0.010 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2001 | 814 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2000 | 2295 | 0.010 |
Why?
|
| Acetaminophen | 1 | 1999 | 544 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1999 | 592 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5100 | 0.010 |
Why?
|
| Age Distribution | 1 | 2000 | 2900 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 1538 | 0.010 |
Why?
|
| HIV Infections | 1 | 2000 | 16678 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2001 | 1339 | 0.010 |
Why?
|
| Social Class | 1 | 2001 | 1995 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1999 | 1737 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2001 | 25575 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1999 | 1606 | 0.010 |
Why?
|
| Risk Factors | 3 | 2001 | 72145 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2009 | 6587 | 0.010 |
Why?
|
| Developing Countries | 1 | 2000 | 2789 | 0.000 |
Why?
|
| Survival Rate | 1 | 2000 | 12773 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1998 | 10248 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2001 | 21719 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 2001 | 3236 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1998 | 15530 | 0.000 |
Why?
|